Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 233,297,860 papers from all fields of science
Search
Sign In
Create Free Account
Meningeal Gliomatosis
Known as:
Gliomatosis of Meninges
, Gliomatosis of the Meninges
, Meninges Gliomatosis
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
9 relations
Central Nervous System
Meninges
Neoplastic Cell
Nervous system structure
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1988
1988
[Ultrastructural study of the growth pattern in an experimental meningeal gliomatosis model].
S. Narumi
,
M. Murakami
,
+5 authors
H. Kanaya
No shinkei geka. Neurological surgery
1988
Corpus ID: 33062768
We tried to examine the growth pattern of meningeal gliomatosis (MG) by using an experimental MG model. C6 rat glioma cells (3 X…
Expand
1987
1987
[Intrathecal ACNU for the treatment of a meningeal gliomatosis model].
T. Yoshida
,
K. Shimizu
,
H. Mogami
,
T. Egawa
,
Y. Sakamoto
Gan to kagaku ryoho. Cancer & chemotherapy
1987
Corpus ID: 35314078
A nitrosourea derivative, ACNU (nimustine hydrochloride), is often used in the chemotherapy of brain tumors and shows…
Expand
1987
1987
[Overcoming of ACNU resistance in an ACNU-resistant subline of rat C6 glioma in vivo through enhanced effect of ACNU by calmodulin inhibitor].
T. Yoshida
,
K. Shimizu
,
T. Hayakawa
,
H. Mogami
,
Y. Sakamoto
,
T. Egawa
No shinkei geka. Neurological surgery
1987
Corpus ID: 38498640
A calmodulin inhibitor, trifluoperazine, was found to enhance the cytotoxic action of ACNU in C6, especially in ACNU-resistant…
Expand
1986
1986
[Development of experimental meningeal gliomatosis models using nude mice].
T. Yoshida
,
K. Shimizu
,
+4 authors
Y. Sakamoto
Gan to kagaku ryoho. Cancer & chemotherapy
1986
Corpus ID: 34391846
Experimental models of meningeal gliomatosis (MG) have been produced by intracisternal inoculation of human glioma cell lines…
Expand
1986
1986
[Clinical studies of adoptive immunotherapy of human disseminated brain tumors with LAK cells and recombinant interleukin-2].
Y. Okamoto
,
K. Shimizu
,
+6 authors
H. Ikeda
No to shinkei = Brain and nerve
1986
Corpus ID: 39190393
In previous in vitro studies, the authors showed that recombinant interleukin-2 (rIL-2) stimulated peripheral blood lymphocytes…
Expand
1986
1986
[Antitumor efficacy of activated macrophages against murine glioma cells].
Y. Miyao
,
K. Shimizu
,
+5 authors
H. Mogami
Gan to kagaku ryoho. Cancer & chemotherapy
1986
Corpus ID: 23250283
A crucial manifestation of malignant gliomas is the regrowth of already-invaded neoplastic cells after surgical intervention. One…
Expand
1984
1984
[Meningeal gliomatosis models as a chemosensitivity assay system].
T. Yoshida
,
K. Shimizu
,
+4 authors
Y. Sakamoto
Gan to kagaku ryoho. Cancer & chemotherapy
1984
Corpus ID: 40013071
Experimental models of meningeal gliomatosis (MG) have been produced by intracisternal inoculation of C6 and 9L glioma cells into…
Expand
1984
1984
[Meningeal gliomatosis: development of experimental models].
T. Yoshida
,
Y. Ushio
,
T. Hayakawa
,
N. Arita
,
K. Yamada
,
H. Mogami
No shinkei geka. Neurological surgery
1984
Corpus ID: 43482673
Experimental models of meningeal gliomatosis (MG) have been produced by intracisternal inoculation of C6 glioma and 9L glioma…
Expand
1981
1981
An unusual case of meningeal gliomatosis.
A. Simonati
,
C. Mazza
,
N. Rizzuto
Acta neuropathologica. Supplementum
1981
Corpus ID: 1407292
A case of meningeal gliomatosis following a primary spinal cord tumor is reported. The clinico-pathological features of this…
Expand
1970
1970
[Study of the pathology of spinal ganglia. Landry-Guillain-Barré syndrome, subacute polyganglionitis, disseminated sclerosis, poliomyelitis, amyotrophic lateral sclerosis, sclerosing…
P. VanGehuchten
1970
Corpus ID: 57905565
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE